Additive effects of raloxifene and alendronate on bone density and biochemical markers of bone remodeling in postmenopausal women with osteoporosis.
(2002) In Journal of Clinical Endocrinology and Metabolism 87(3). p.92-985
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/115518
- author
- Johnell, Olof LU ; Scheele, Wim H ; Lu, Yili ; Reginster, Jean-Yves ; Need, Allan G and Seeman, Ego
- organization
- publishing date
- 2002
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Non-U.S. Gov't, Osteoporosis, Bone Density: drug effects, Biological Markers: blood, Alendronate: therapeutic use, Aged, Bone Remodeling: drug effects, Lumbar Vertebrae: drug effects, Human, Femur Neck: physiopathology, Femur Neck: drug effects, Female, Drug Synergism, Double-Blind Method, Collagen: antagonists & inhibitors, Bone Remodeling: physiology, Lumbar Vertebrae: physiopathology, Osteocalcin: antagonists & inhibitors, Middle Age, Postmenopausal: drug therapy, Postmenopausal: physiopathology, Peptides: antagonists & inhibitors, Raloxifene: therapeutic use, Selective Estrogen Receptor Modulators: therapeutic use, Support
- in
- Journal of Clinical Endocrinology and Metabolism
- volume
- 87
- issue
- 3
- pages
- 92 - 985
- publisher
- Oxford University Press
- external identifiers
-
- scopus:0036963450
- ISSN
- 1945-7197
- language
- English
- LU publication?
- yes
- id
- 667a8443-1e3c-4175-9a28-6d8db4fef2f0 (old id 115518)
- alternative location
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11889149&dopt=Abstract
- date added to LUP
- 2016-04-01 16:34:55
- date last changed
- 2024-05-24 08:41:19
@article{667a8443-1e3c-4175-9a28-6d8db4fef2f0, author = {{Johnell, Olof and Scheele, Wim H and Lu, Yili and Reginster, Jean-Yves and Need, Allan G and Seeman, Ego}}, issn = {{1945-7197}}, keywords = {{Non-U.S. Gov't; Osteoporosis; Bone Density: drug effects; Biological Markers: blood; Alendronate: therapeutic use; Aged; Bone Remodeling: drug effects; Lumbar Vertebrae: drug effects; Human; Femur Neck: physiopathology; Femur Neck: drug effects; Female; Drug Synergism; Double-Blind Method; Collagen: antagonists & inhibitors; Bone Remodeling: physiology; Lumbar Vertebrae: physiopathology; Osteocalcin: antagonists & inhibitors; Middle Age; Postmenopausal: drug therapy; Postmenopausal: physiopathology; Peptides: antagonists & inhibitors; Raloxifene: therapeutic use; Selective Estrogen Receptor Modulators: therapeutic use; Support}}, language = {{eng}}, number = {{3}}, pages = {{92--985}}, publisher = {{Oxford University Press}}, series = {{Journal of Clinical Endocrinology and Metabolism}}, title = {{Additive effects of raloxifene and alendronate on bone density and biochemical markers of bone remodeling in postmenopausal women with osteoporosis.}}, url = {{http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11889149&dopt=Abstract}}, volume = {{87}}, year = {{2002}}, }